/
Musculoskeletal
Osteoarthritis
110
Pipeline Programs↗
277
Active Trials↗
148
Companies Involved↗
Osteoarthritis is a highly competitive landscape with 110 programs across 148 companies. The most active players are Doron Therapeutics Inc., Pacira Pharmaceuticals, Inc, Ageless Biotech, Inc.. 15 programs are in Phase 3.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
Preclinical70
Phase 18
Phase 217
Phase 315
Approved
No programs
Analysis
Modality Breakdown
93%
Small molecule
79 of 85 classified programs — the dominant modality here.
Small molecule leads; the ring shows all 85 classified programs, each share of the total. Modality classified for 95% of 110 pipeline programs.
Analysis
Trial Status
1,191
clinical trials
Completed682 · 57%
Recruiting139 · 12%
Unknown status127 · 11%
Not yet recruiting81 · 7%
Terminated68 · 6%
Active, not recruiting51 · 4%
Other43 · 4%
Clinical Trials
Trial Activity
1191 trials
Efficacy of Acupuncture for Patients With Hand Osteoarthritis: a Randomized, Sham-controlled Trial
Recruiting·GGuang'anmen Hospital of China Academy of Chinese Medical Sciences·Preclinical·NCT05267093·340 enrolled
Page 1 of 80
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)